BioStock: Respiratorius’ CEO comments on an eventful year

When Respiratorius’ CEO Johan Drott sums up 2022, he looks back on a transformative year. Arcede Pharma was spun off, a new formulation of VAL001 was developed and now the company is looking for a partner to advance the project further. BioStock contacted Drott in connection with the release of the Q3 report to learn more.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/02/respiratorius-ceo-comments-on-an-eventful-year/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se